Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026)
Precigen (PGEN) reported Change in Acquisitions & Divestments of $55.1 million for Q1 2026, up 1104.88% year-over-year from $4.6 million in Q1 2025, and down 13.56% quarter-over-quarter from $63.7 million in Q4 2025.
Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Change in Acquisitions & Divestments data on file, last reported at $55.1 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $55.1 million, up 1104.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $259.0 million (up 93.27% YoY), and the FY2025 annual result was $208.5 million, up 19.11% from the prior year.
- Change in Acquisitions & Divestments declined to $55.1 million in Q1 2026 per PGEN's latest filing, from $63.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $82.3 million in Q3 2025 and troughed at $4.6 million in Q1 2025.
- A 5-year average of $40.6 million and a median of $45.6 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments tumbled 89.97% in 2025, then jumped 1104.88% in 2026.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $11.5 million in 2022, then surged by 297.67% to $45.6 million in 2023, then increased by 5.24% to $48.0 million in 2024, then surged by 32.74% to $63.7 million in 2025, then retreated by 13.56% to $55.1 million in 2026.
- Business Quant data shows PGEN's Change in Acquisitions & Divestments at $55.1 million in Q1 2026, $63.7 million in Q4 2025, and $82.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.10 Mn |
| Mar 31, 2026 | 55.10 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Jun 30, 2025 | 57.88 Mn |
| Jun 30, 2025 | 57.88 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 51.75 Mn |
| Jun 30, 2024 | 51.75 Mn |
| Mar 31, 2024 | 45.58 Mn |
| Mar 31, 2024 | 45.58 Mn |
| Dec 31, 2023 | 45.63 Mn |
| Dec 31, 2023 | 45.63 Mn |